SleepQuest: sleep and mental health during the COVID-19 pandemic
5 May 2020
Good sleep is critical for wellbeing – including dementia prevention and good mental health. But the COVID-19 pandemic and lockdown is placing people under huge stress, which may disturb sleep. Disturbed sleep now may have an impact on current and future health for all, in particular those at risk of dementia. The SleepQuest study needs to hear about your experiences to understand the effect that the outbreak is having and create advice on how to manage sleep throughout this crisis and beyond.
How are COVID-19 closures affecting people with dementia and their carers?
21 April 2020
Due to the Coronavirus pandemic, many of the face-to-face services people with dementia and their carers often rely on are temporarily closed. Researchers need your help to understand the impact of these closures on the wellbeing of people with dementia and their carers.
Remembering names through computer therapy
12 August 2019
The ‘Gotcha!’ study is trialling a fun computer-based therapy to help people with dementia remember the names of the people who are important to them.
Driving and dementia: share your experience
4 July 2019
Help researchers to improve the guidance and support around driving after a dementia diagnosis by taking part in a survey to share your experience.
What’s that study? Investigating thinking and emotional regulation styles in older adults
18 February 2019
We spoke to Anne-Marie Greenaway, PHD student at the University of Reading, who is leading a study to investigate the emotional wellbeing of people living with dementia. When someone experiences a low mood, it makes it more difficult to complete everyday tasks. Low mood increases the level of cognitive impairment in people living with dementia. As approximately half the number of […]
‘Exercise hormone’ may play a role in combating Alzheimer’s disease
14 January 2019
This article has been reproduced from the NHS website. “An ‘exercise pill’ mimicking the effects of a gym workout could prevent Alzheimer’s disease,” the Daily Mirror reports. The “pill” is actually a reference to a protein called irisin. Irisin has been dubbed the “exercise hormone” because previous research found it’s released from muscles in response to […]
What’s that study? The Generation Program
26 November 2018
We caught up with Professor Lefkos Middleton from Imperial College London, who is UK Chief Investigator for the Generation Program. The Generation Program is a collaboration between Novartis, Amgen and Banner Alzheimer’s Institute, and consists of two clinical trials that may be able to delay the onset of Alzheimer’s disease – Generation Study 1 and […]
What’s that study? Uncertainty and Caregiving
22 October 2018
We caught up with Alan Galvin, Chief Investigator for the ‘Uncertainty and Caregiving Study: Intolerance of Uncertainty and Strain in the Caregivers of People with Dementia’. What are the main aims of this study? The majority of care for people with dementia is provided by informal family caregivers. While experience of caring can be positive and […]
What’s that study? Living Alone with Dementia
18 October 2018
We caught up with Courtney Poole, PhD student at the University of Coventry, who is leading the ‘Living Alone with Dementia’ study. What are the main aims of ‘Living Alone with Dementia? This study aims to learn about the experience of living alone with dementia. It is thought that around a third of people with dementia […]
Landmark trial for novel Alzheimer’s disease treatment
9 October 2018
This story was first published on the NIHR website. The first clinical trial of a completely novel and unprecedented approach to modifying the progression of Alzheimer’s disease has opened at the NIHR University College London Hospitals (UCLH) Clinical Research Facility. The Depletion of serum amyloid P component in Alzheimer’s disease (DESPIAD) trial will test whether […]